https://doi.org/10.55788/70e9c8de
Prof. Jesus Almendral (HM University Hospital, Spain) and co-investigators conducted a randomised trial (NCT02274168) that hypothesised that the information retrieved from ICD-EG during ablation in patients with structural heart disease and an indication for VT ablation leads to an accurate distinction between clinically and non-clinically induced VT and allows pace mapping [1]. This would instigate a more focalised ablation on the VT and result in a more successful procedure. The 260 included patients were randomised 1:1 to the ICD-EG arm or the conventional ablation arm.
The ICD-EG procedure was significantly associated with a clearer distinction between clinically and non-clinically induced VT compared with the conventional procedure (P<0.001). Also, pace mapping was more applicable in the experimental arm than in the control arm (P<0.001). However, the primary endpoint of VT recurrence at 6 months was not met: 36% in the ICD-EG arm versus 46% in the conventional arm (HR 0.73; Plog-rank=0.1). The number of VT recurrences (P=0.0001) and the occurrence of arrhythmic storms (Plog-rank=0.007), which were secondary endpoints of the study, were significantly lower in the ICD-EG arm than in the conventional arm, suggesting there might be a benefit from the experimental procedure.
- Almendral J, et al. Aid of recording ICD electrograms during monomorphic ventricular tachycardia ablation procedures. Late-Breaking Science Day 2, EHRA 2023, 16–18 April, Barcelona, Spain.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Prolonged ECG monitoring detects relevant arrhythmias in HCM Next Article
Promising results for Marshall Plan ablation strategy »
« Prolonged ECG monitoring detects relevant arrhythmias in HCM Next Article
Promising results for Marshall Plan ablation strategy »
Table of Contents: EHRA 2023
Featured articles
CEASE-AF meets primary endpoint in persistent AF
ANTWERP score selects HF patients for AF ablation
Ablation for Atrial Fibrillation
Surgery saves lives in patients with oesophageal fistula
MANIFEST-PF: Good results for the pentaspline PFA catheter
POWER FAST III: High-power, short-duration radiofrequency ablation for AF
High-power, short-duration ablation linked to a higher stroke risk
Early or delayed ablation for AF?
CEASE-AF meets primary endpoint in persistent AF
Promising results for Marshall Plan ablation strategy
Updates on Devices
Can ICD-EG-derived information improve ventricular tachycardia ablation outcomes?
Prolonged ECG monitoring detects relevant arrhythmias in HCM
Does adaptive pacing work in patients with HF, LBBB, and intact AV conduction?
Can we identify patients who may not benefit from ICD therapy?
Miscellaneous
Statins display benefits for AF patients in a large population-based study
ANTWERP score selects HF patients for AF ablation
Epicardial ablation successful in Brugada syndrome
Highly increased risk of arrhythmias after mechanical ventilation for COVID-19
Related Articles
November 25, 2021
‘Glimpse of hope’ when anti-CD20 drugs limit vaccine antibodies
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com